Metabolomic Profiling to Identify Potential Serum Biomarkers for Schizophrenia and Risperidone Action-Reference-Cited by-同舟云学术

Metabolomic Profiling to Identify Potential Serum Biomarkers for Schizophrenia and Risperidone Action

Published:2011-11-08 Issue:12 Volume:10 Page:5433-5443
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Xuan Jiekun¹²,Pan Guihua³,Qiu Yunping⁴,Yang Lun¹,Su Mingming⁵,Liu Yumin⁶,Chen Jian¹,Feng Guoyin³,Fang Yiru³,Jia Wei⁴,Xing Qinghe¹⁷,He Lin¹⁷²

Affiliation:

1. Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China

2. Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China

3. Shanghai Institute of Mental Health, Shanghai 200030, China

4. Department of Nutrition, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, North Carolina 28081, United States

5. David H. Murdock Research Institute, Kannapolis, North Carolina 28081, United States

6. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

7. Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr2006796

Reference65 articles.

1. Schizophrenia: Diverse Approaches to a Complex Disease

2. Broad therapeutic uses of atypical antipsychotic medications